Watson-Marlow Fluid Technology Solutions launches WMArchitect™ Interchangeable Parts to provide greater supply agility for single-use assemblies

• Interchangeable Parts incorporates pre-qualified, alternative components in the design stage of your single-use assembly
• Alongside the full WMArchitect™ single-use solutions range, Interchangeable Parts is fully supported by our experienced specialist scientists and Validation Testing team
• WMFTS uses the BioPhorum best practice equivalency assessment method to eliminate compatibility, performance and safety concerns

Falmouth, UK, 9th June 2025 / Watson-Marlow Fluid Technology Solutions (WMFTS) has introduced WMArchitect™ Interchangeable Parts to secure a resilient supply of single-use assemblies by including pre-qualified, alternative components in the design stage to avoid regulatory compliance interruptions and long lead times.

The new service for bioprocessing eliminates the disruption of reduced component stock and potential production shutdowns, to instead enable a simplified way to substitute in suitable components with shorter lead times.

Interchangeable Parts provides qualified, alternative component options in an assembly which are agreed during the design stage. This avoids supply constraints of a specific component, such as tubing, tri-clamps and other tube fittings.

Alongside the full WMArchitect™ single-use solutions range from WMFTS, Interchangeable Parts is fully supported by experienced specialist scientists and a Validation Testing team. WMFTS uses the BioPhorum best practice equivalency assessment method to eliminate compatibility, performance and safety concerns.

Interchangeable Parts offers biopharmaceutical companies a flexible solution to the uncertainty of choosing substitute components and the absence of clear guidance in standardised criteria.

Dr. Nicole Hunter, Head of WMArchitect single-use solutions at WMFTS, said: “Based on sound science and detailed process understanding, we work with our customers to assess form, fit and function for alternative components. Interchangeable components are then advised during the early assembly design stage of your assembly specification.

“We proactively monitor the lead times of components to track whether there are gradual or sudden changes. When a component flags, we can pivot quickly to source a pre-agreed alternative with a shorter lead time. Alternative components can be from WMFTS or from a third-party.

“We’ve adopted the BioPhorum best practice equivalency assessment method to address any concerns over compatibility, performance and safety. Full compliance and traceability is maintained, and by swapping in a component that is more easily available we can limit any disruption to your workflow.

“During the COVID-19 pandemic, as an industry we were not sufficiently resilient to the extreme surge in single-use technology demand. In order to future-proof supply, Interchangeable Parts brings a flexibility and versatility to your process to ensure a simplified, efficient change management which gives greater confidence to regulators.”

Features and benefits:

• Avoid the disruption of long lead times by ensuring a resilient supply of single-use components and uninterrupted production
• Mitigates regulatory complications associated with interchangeable components
• WMFTS uses the BioPhorum best practice equivalency assessment method to eliminate compatibility, performance and safety concerns
• Process agility while maintaining full traceability and quality assurance

WMArchitect single-use solutions, which was launched last year, is an end-to-end biopharmaceutical fluid management solution from a single supplier. WMArchitect single-use solutions is designed to offer both standard, ready-to-use single-use assemblies as well as customised designs that are fully supported with tailored validation packages.

ENDS

For further information, please contact:

Sciad Communications, Media Relations
Juliette Craggs / Jasmin Shearan
E: watsonmarlow@sciad.com
T: +44 (0)20 3405 7892

Notes for editors

About Watson-Marlow Fluid Technology Solutions

Watson-Marlow Fluid Technology Solutions (WMFTS) is a world leader in manufacturing peristaltic pumps and associated fluid path technologies for the life sciences and process industries.

As a leading provider of peristaltic and sine pumps, automated filling machines, tubing, hoses, fluid path components and post-sales support technology, WMFTS partners with customers to solve challenges across various applications.

WMFTS is a wholly owned subsidiary of Spirax Group, with operating units worldwide.

Further information can be found at www.wmfts.com